您的位置: 首页 > 农业专利 > 详情页

NOUVEAUX ANTICORPS ANTI-CD3EPSILON
专利权人:
WUXI BIOLOGICS IRELAND LIMITED
发明人:
LI, JING,MEI, QIN
申请号:
CA3074130
公开号:
CA3074130A1
申请日:
2018.09.20
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
Provided are isolated monoclonal anti-CD3epsilon antibodies or antigen-bindingfragments thereof comprising one ormore heavy chain CDR sequences selected from the group consisting of: SEQ IDNOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27,29, 31, 33, 35, 37, 39, 41, 43, 45, and 47, and/or one or more kappa lightchain CDR sequences selected from the group consisting of:SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34,36, 38, 40, 42, 44, 46 and 48. Further provided are isolatedpolynucleotides encoding the same, pharmaceutical compositions comprising thesame, and the use thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充